Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Oxford Optronix Launches HypoxyLab™

Published: Thursday, November 14, 2013
Last Updated: Thursday, November 14, 2013
Bookmark and Share
HypoxyLab™ provides a physiologically reproducible, contamination-free, low oxygen/hypoxia environment to create optimal conditions for life science and clinical medicine research.

Oxford Optronix has announced the formal launch of HypoxyLab™ - the industry’s first benchtop, HEPA-filtered, precision-controlled hypoxia workstation.

HypoxyLab creates optimal, contamination-free conditions for a wide variety of cell-based research fields, including cancer biology, radiation cell biology, cardiovascular research, apoptosis, neurology, stem cell research, multidisciplinary drug development and proteomics.

HypoxyLab is a unique, fully-featured and easy-to-use hypoxia workstation that accurately reproduces physiological conditions for cell-based research.

HypoxyLab provides a highly stable, localized environment in which levels of oxygen, carbon dioxide, temperature and humidity are precisely controlled within a HEPA-filtered isolation work chamber.

Using the optional OxyLite™ module, HypoxyLab also uniquely offers support for direct oxygen partial pressure (pO2) measurements from cell media or tissue using fibre-optic sensors.

The ergonomically-designed benchtop workstation maintains ultra-stable climatic conditions using processor-controlled temperature and the latest nebulizer-based, humidifier technology - delivering requisite levels of humidity whilst maintaining a Class 5 environment.

Precision concentrations of O2 and CO2 as well as chamber temperature and humidity are controlled via a color touch-screen display and delivered using unique, electronic gas flow controllers and auto-calibrating, sensors.

The workstation displays real-time values of chamber O2, CO2, Temperature and Humidity on the touch-screen and simultaneously records this information onto a USB memory stick for off-line analysis.

HypoxyLab’s highly optimized working volume ensures ultra-rapid cell cycling and tissue response times, whilst precise oxygen profiling and cycling is controlled via the intuitive graphical user interface. This allows researchers to easily create any number of bespoke oxygen profiling patterns.

In tissue culture technology, there is a growing need for systems capable of creating precise and reproducible mammalian cell environments - now recognized as vital for accurate analysis of both cell metabolism and cell function.

However, a significant proportion of cell biology research is still performed in ‘traditional incubators’, in which cells are routinely exposed to the oxygen values found in air - at least two or three times the value expected in normal tissues - leading to cellular stress, significant physiological changes which influence differentiation, growth factor signaling and other cellular processes including post-translational metabolic pathways.

By delivering a contamination-free environment that offers precise and continuous control of O2, CO2, temperature and humidity, Oxford Optronix’s new HypoxyLab workstation delivers a powerful new solution to research teams looking to accurately reproduce real-life physiological conditions in cell-based research.

Commenting on the launch, Andy Obeid PhD, CEO of Oxford Optronix said: “With the growing industry-wide recognition of the need to create physiologically reproducible, low oxygen and hypoxic environments for mammalian cells in the laboratory, we were determined to create a solution for our customers that combines cost-effectiveness and a small form factor with unrivalled accuracy and precision. Our new HypoxyLab is easy to use, economic to run and delivers the industry’s first benchtop, HEPA-filtered hypoxia workstation with applicability for every cell-based research laboratory.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Stem Cells Know How to Unwind
Research led by the Babraham Institute with collaborators in the UK, Canada and Japan has revealed a new understanding of how an open genome structure supports the long-term and unrestricted developmental potential in embryonic stem cells.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!